Acetic Acid

Acetic Acid

SCHEMBL630646

CC(=O)[O-].CC(=O)[O-].CCCCCCCCCCCC[Sn+2]CCCCCCCCCCCC

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 known ✓ P03372 1/20 0.41
CES1 P23141 5/20 0.48
CES2 O00748 4/20 0.48
CA2 P00918 1/20 0.42
PPARG P37231 6/20 0.41
PPARD Q03181 6/20 0.41
PPARA Q07869 6/20 0.41
GPR84 Q9NQS5 5/20 0.41
HDAC11 Q96DB2 5/20 0.41
TSHR P16473 4/20 0.41
ALDH1A1 P00352 2/20 0.41
TLR2 O60603 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
FABP4 P15090 2/20 0.41
PTPN1 P18031 2/20 0.41
SLC22A6 Q4U2R8 1/20 0.41
SLC22A8 Q8TCC7 1/20 0.41
MEN1 O00255 1/20 0.41
ALOX15 P16050 1/20 0.41
PDE4A P27815 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL3826722 1.00 CES1 (0.48) CES1CES2CA2PPARGPPARD
Acetic Acid SCHEMBL29714835 1.00 CES1 (0.48) CES1CES2CA2PPARGPPARD
Acetic Acid SCHEMBL123724 1.00 CES1 (0.48) CES1CES2CA2PPARGPPARD
Acetic Acid SCHEMBL4445253 1.00 CES1 (0.48) CES1CES2CA2PPARGPPARD
Oxalic Acid SCHEMBL10749415 0.91 CES2 (0.48) CES1CES2CA2PPARGPPARD
Bicarbonate SCHEMBL28052430 0.91 CES2 (0.48) CES1CES2CA2PPARGPPARD
Acetic Acid SCHEMBL37323 0.90 CES1 (0.44) CES1CES2CA2ALDH1A1CA1
Dodecanoate SCHEMBL18076263 0.90 FABP3 (0.56) CES1CES2GPR84FABP3CA1
SCHEMBL384850 0.89 CES2 (0.43) CES1CES2CA2PPARGPPARD
SCHEMBL30353010 0.89 CES2 (0.43) CES1CES2CA2PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113710718-B Stabilized silane-modified polymer compositions and methods 迈图高新材料公司 2024-06-25 CN claimed
CN-111212861-B Urethane acrylate hybrid structural adhesive 阿科玛法国 2022-10-25 CN claimed
EP-1569979-B1 USE OF A MATERIAL FOR NOISE PROTECTION DEVICES, SWIMMING PROTECTION DEVICES, OTOPLASTICS AND FOR SECURING VENTINGS AND METHOD FOR THE PRODUCTION OF SAID PARTS DREVE OTOPLASTIK GMBH (DE) 2012-02-22 EP claimed
EP-1569979-A1 USE OF A MATERIAL FOR NOISE PROTECTION DEVICES, SWIMMING PROTECTION DEVICES, OTOPLASTICS AND FOR SECURING VENTINGS AND METHOD FOR THE PRODUCTION OF SAID PARTS Dreve Otoplastik Gmbh (DE) 2005-09-07 EP claimed
WO-2004052957-A1 USE OF A MATERIAL FOR NOISE PROTECTION DEVICES, SWIMMING PROTECTION DEVICES, OTOPLASTICS AND FOR SECURING VENTINGS AND METHOD FOR THE PRODUCTION OF SAID PARTS DREVE OTOPLASTIK GMBH (DE) 2004-06-24 WO claimed
EP-0607900-B1 Resin composition for artificial marble, bulk molding compound and sheet molding compound using the same, and process for preparing artificial marble using the same HITACHI CHEMICAL CO LTD (JP) 1999-04-14 EP claimed
WO-2026104544-A1 EXO-VINYLENE CARBONATE COMPOUNDS AS PRECURSORS FOR ISOCYANATE-FREE URETHANE-TYPE POLYMERS BASF SE (DE) 2026-05-21 WO disclosed
EP-4745170-A1 METHOD FOR PREPARING A URETHANE GROUP-CONTAINING POLYMER BASF SE (DE) 2026-05-20 EP disclosed
EP-4745169-A1 COMPOSITION USEFUL AS COATING, SEALANT OR ADHESIVE BASF SE (DE) 2026-05-20 EP disclosed
US-20260132310-A1 HIGH STRENGTH URETHANE ACRYLATE HYBRID STRUCTURE ADHESIVES ARKEMA FRANCE (FR) 2026-05-14 US disclosed
US-12624164-B2 Synthetic thickeners incorporating non-reactive diluents HERCULES LLC (US) 2026-05-12 US disclosed
EP-4735497-A1 DUAL CURE ADHESIVE COMPOSITION Momentive Performance Materials Inc. (US) 2026-05-06 EP disclosed
US-12617891-B2 Flexible foams comprising additives for improving hardness MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2026-05-05 US disclosed
WO-2004052957-A1 USE OF A MATERIAL FOR NOISE PROTECTION DEVICES, SWIMMING PROTECTION DEVICES, OTOPLASTICS AND FOR SECURING VENTINGS AND METHOD FOR THE PRODUCTION OF SAID PARTS DREVE OTOPLASTIK GMBH (DE) 2004-06-24 WO disclosed
EP-1340484-A1 Dental materials based on substituted imino oxadiazindione derivatives Ivoclar Vivadent AG (LI) 2003-09-03 EP disclosed
EP-0872502-B1 Water-dispersed radiation-curable polyurethanes SYNTHOPOL CHEMIE DR KOCH (DE) 2003-06-04 EP disclosed
EP-0911352-A2 Baking coating and its use BAYER AG (DE) 1999-04-28 EP disclosed
EP-0872502-A1 Water-dispersible radiation-curable polyurethanes SYNTHOPOL CHEMIE Dr. rer. pol. Koch GmbH & CO. KG (DE) 1998-10-21 EP disclosed
EP-0044393-B1 PROCESS FOR PREPARING A(N) (METH)ACRYLIC RESIN MODIFIED WITH EPSILON-CAPROLACTONE AND HAVING HYDROXYL GROUPS Degussa Aktiengesellschaft (DE) 1984-09-19 EP disclosed
EP-0044393-A2 Process for preparing a(n) (meth)acrylic resin modified with epsilon-caprolactone and having hydroxyl groups Degussa Aktiengesellschaft (DE) 1982-01-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12624164-B2 Synthetic thickeners incorporating non-reactive diluents GEMIN4, MAGT1, SETDB1 ESR1 3561/4885CES1 2482/4885CES2 3479/4885
US-12617891-B2 Flexible foams comprising additives for improving hardness SMC3, SMCHD1, SMC2 ESR1 1199/4885CES1 3624/4885CES2 2047/4885
US-20260132310-A1 HIGH STRENGTH URETHANE ACRYLATE HYBRID STRUCTURE ADHESIVES HSPB1, PTK2, ICAM1 ESR1 2136/4885CES1 4448/4885CES2 1416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.